Skip to content

Genpact

US · G #2004 by market cap Listed 1970
41.50 +0.66 +1.62%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 41.20 +0.88%
After-hours 41.50 0.00%
44.2827.3541.502026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on G?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +4.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 6.4% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A
ValuationGrowthProfitMomentumHealthAnalyst
Valuation A-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 12.1x Better than 70%
Forward P/E 11.3x Better than 71%
Price / Sales 1.4x Better than 69%
P/E vs own 5-yr range 34th pctl Better than 73%
Growth B+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 5.1% Better than 47%
Net income CAGR (3Y) 16.1% Better than 68%
Free cash flow CAGR (3Y) 23.0% Better than 67%
Profitability B+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 36.0% Better than 42%
Operating margin 15.0% Better than 65%
Net margin 10.9% Better than 62%
Return on equity 22.4% Better than 81%
Return on invested capital 14.5% Better than 81%
Momentum A-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 12.3% Better than 92%
6-month return 31.5% Better than 90%
12-month return (ex latest month) -6.5% Better than 26%
Distance below 52-week high 13.3% Better than 76%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.7x Better than 47%
Debt to assets 30.2% Better than 41%
Interest coverage 10.9x Better than 74%
Free cash flow / net income 131.1% Better than 58%
Analyst View D+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 37.5% Better than 20%
Upside to average target 14.6% Better than 22%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -4.84%
1M +7.24%
3M +12.98%
6M +30.66%
YTD -9.85%
1Y -3.56%
3Y +27.36%
5Y -12.22%

Key statistics

Price & volume

Prev close
40.84
Open
41.34
Day range
41.25 - 42.34
Avg price
41.79
Volume
1.77M
Turnover
73.78M
Amplitude
2.68%
52-week range
26.71 - 47.87

Valuation

P/E
13.26
P/E (TTM)
12.10
P/B
2.56
EPS
3.13
Net profit
523.42M
Net assets
2.71B

Share structure

Market cap
6.94B
Float cap
5.92B
Shares out
167.23M
Float shares
142.60M

Dividend & listing

Dividend (TTM)
0.73
Listing date
1970-01-01
52-week range 70% of range
26.71 47.87

13.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+21.38M net over the window

Short interest

Shares short
10.68M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Genpact (G)?

Genpact last traded at 41.50. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Genpact's market cap?

About 6.94B.

What is the P/E ratio of Genpact?

The trailing twelve-month P/E is 12.10, below its own 5-year average of 16.65 — in the middle of its historical range (34.13% percentile). See the Valuation tab for the full history.

Does Genpact pay a dividend?

Yes. The trailing dividend yield is 1.77%. The 2025 payout was up 11.5% from 2024. See the Dividends tab for the full payment history.

Is Genpact a buy according to analysts?

The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 47.57, which implies 14.6% upside from the current price. This is not investment advice.

What is Genpact's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Genpact a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Genpact discussion 0 comments

Add a comment